XML 171 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Working capital (Tables)
12 Months Ended
Jun. 30, 2023
Summary Of Additional Information About Working Capital [Abstract]  
Schedule of inventories
(a) Inventories
 2023
£ million
2022
£ million
Raw materials and consumables
543 489 
Work in progress
132 86 
Maturing inventories
5,794 5,229 
Finished goods and goods for resale
1,192 1,290 
7,661 7,094 
Schedule of inventories expected to be utilised after more than one year
Maturing inventories include whisk(e)y, rum, tequila and Chinese white spirits. The following amounts of inventories are expected to be utilised after more than one year:
 2023
£ million
2022
£ million
Raw materials and consumables
23 15 
Maturing inventories
4,063 3,713 
4,086 3,728 
Schedule of provisions for obsolescence of inventories
Inventories are disclosed net of provisions for obsolescence, an analysis of which is as follows:
 2023
£ million
2022
£ million
2021
£ million
Balance at beginning of the year
94 96 98 
Exchange differences
(27)(8)
Income statement charge55 20 
Utilised(19)(13)(14)
Sale of businesses
(1)(1)— 
102 94 96 
Schedule of trade and other receivables
(b) Trade and other receivables

 20232022
 Current
assets
£ million
Non-current
assets
£ million
Current
assets
£  million
Non-current
assets
£ million
Trade receivables
2,011  2,155 — 
Interest receivable
12  18 — 
VAT recoverable and other prepaid taxes271 15 290 15 
Other receivables
163 13 158 13 
Prepayments
229 3 290 
Accrued income
34  22 — 
2,720 31 2,933 37 
Schedule of aged analysis of trade receivables net of allowances
The aged analysis of trade receivables, net of expected credit loss allowance, is as follows:
 2023
£ million
2022
£ million
Not overdue
1,967 2,114 
Overdue 1 – 30 days
25 19 
Overdue 31 – 60 days
7 
Overdue 61 – 90 days
3 
Overdue 91 – 180 days
6 
Overdue more than 180 days
3 
2,011 2,155 
Schedule of expected credit loss allowance for doubtful debts
Trade and other receivables are disclosed net of expected credit loss allowance for doubtful debts, an analysis of which is as follows:
 2023
£ million
2022
£ million
2021
£ million
Balance at beginning of the year
118 112 160 
Exchange differences
(12)(13)
Income statement (release)/charge
(3)21 (15)
Written off
(14)(21)(20)
89 118 112 
Schedule of trade and other payables
(c) Trade and other payables
 20232022
 Current
liabilities
£ million
Non-current
liabilities
£ million
Current
liabilities
£ million
Non-current
liabilities
£ million
Trade payables
2,659  2,705 — 
Interest payable
237  143 — 
Tax and social security excluding income tax632  696 — 
Other payables
432 368 600 380 
Accruals
1,229  1,635 — 
Deferred income
73  90 — 
Dividend payable to non-controlling interests38  18 — 
5,300 368 5,887 380 
Schedule of movement in provisions
(d) Provisions
Thalidomide
£ million
Other
£ million
Total
£ million
At 30 June 2022178 239 417 
Exchange differences
(1)(26)(27)
Disposal of businesses
 (2)(2)
Provisions charged during the year
 31 31 
Provisions utilised during the year
(14)(61)(75)
Transfers from other payables
 12 12 
Unwinding of discounts
5 1 6 
At 30 June 2023168 194 362 
Current liabilities
13 106 119 
Non-current liabilities
155 88 243 
168 194 362